应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
JBIO Jade Biosciences
休市中 12-12 16:00:00 EST
14.98
+0.14
+0.94%
盘后
15.27
+0.29
+1.94%
19:16 EST
最高
15.33
最低
14.64
成交量
28.52万
今开
14.96
昨收
14.84
日振幅
4.67%
总市值
6.89亿
流通市值
4.81亿
总股本
4,600万
成交额
429.08万
换手率
0.89%
流通股本
3,214万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Jade Biosciences提交最多1610万股普通股的出售申请 - SEC备案
投资观察 · 11-20
Jade Biosciences提交最多1610万股普通股的出售申请 - SEC备案
Jade Biosciences Inc 提交出售股东最多 1610 万股普通股的注册申请 - SEC备案
美股速递 · 11-15
Jade Biosciences Inc 提交出售股东最多 1610 万股普通股的注册申请 - SEC备案
Jade Biosciences宣布推出Jade201——一款在研的潜在同类最佳半衰期延长去岩藻糖化抗BAFF受体单克隆抗体,用于治疗自身免疫性疾病
美股速递 · 10-07
Jade Biosciences宣布推出Jade201——一款在研的潜在同类最佳半衰期延长去岩藻糖化抗BAFF受体单克隆抗体,用于治疗自身免疫性疾病
Jade Biosciences预计2026年上半年公布富含生物标志物的1期健康志愿者中期数据
美股速递 · 09-02
Jade Biosciences预计2026年上半年公布富含生物标志物的1期健康志愿者中期数据
Jade Biosciences宣布新型抗APRIL单抗药物Jade101的1期健康志愿者临床试验完成首批受试者给药
美股速递 · 09-02
Jade Biosciences宣布新型抗APRIL单抗药物Jade101的1期健康志愿者临床试验完成首批受试者给药
Guggenheim:上调Jade Biosciences(JBIO.US)评级,由中性调整至买入评级, 目标价14.00美元。
金融界 · 06-16
Guggenheim:上调Jade Biosciences(JBIO.US)评级,由中性调整至买入评级, 目标价14.00美元。
加载更多
公司概况
公司名称:
Jade Biosciences
所属市场:
NASDAQ
上市日期:
--
主营业务:
Jade Biosciences, Inc.是内华达州的一家公司,专注于开发一流的疗法,以解决自身免疫性疾病中关键的未满足需求。其牵头资产JADE-001针对免疫球蛋白A(IGA)肾病的细胞因子抗-A PRoliferation诱导Ligand(APRIL),正在进行研究性新药应用赋能研究,预计将于2025年下半年启动首次人体试验。Jade的管线还包括两个未公开的抗体发现项目,JADE-002和JADE-003,目前处于临床前开发阶段。
发行价格:
--
{"stockData":{"symbol":"JBIO","market":"US","secType":"STK","nameCN":"Jade Biosciences","latestPrice":14.98,"timestamp":1765573200000,"preClose":14.84,"halted":0,"volume":285164,"hourTrading":{"tag":"盘后","latestPrice":15.27,"preClose":14.98,"latestTime":"19:16 EST","volume":2954,"amount":44284.161,"timestamp":1765584985084},"delay":0,"floatShares":32137430,"shares":46004205,"eps":-18.7916,"marketStatus":"休市中","change":0.14,"latestTime":"12-12 16:00:00 EST","open":14.96,"high":15.3332,"low":14.6401,"amount":4290794.26864,"amplitude":0.046705,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-18.7916,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":14.84,"preHourTrading":{"tag":"盘前","latestPrice":15.76,"preClose":14.84,"latestTime":"08:24 EST","volume":57,"amount":901.530069,"timestamp":1765545894654},"postHourTrading":{"tag":"盘后","latestPrice":15.27,"preClose":14.98,"latestTime":"19:16 EST","volume":2954,"amount":44284.161,"timestamp":1765584985084},"volumeRatio":0.7600769115538959,"impliedVol":1.0293,"impliedVolPercentile":0.6806},"requestUrl":"/m/hq/s/JBIO","defaultTab":"news","newsList":[{"id":"1168065668","title":"Jade Biosciences提交最多1610万股普通股的出售申请 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1168065668","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168065668?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:50","pubTimestamp":1763574644,"startTime":"0","endTime":"0","summary":"11月14日 - Jade Biosciences Inc: *Jade Biosciences Inc提交最多1610万股普通股的出售申请 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"gpt_icon":0},{"id":"1138728748","title":"Jade Biosciences Inc 提交出售股东最多 1610 万股普通股的注册申请 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1138728748","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138728748?lang=zh_cn&edition=full","pubTime":"2025-11-15 05:16","pubTimestamp":1763154970,"startTime":"0","endTime":"0","summary":"Jade Biosciences Inc 提交出售股东最多 1610 万股普通股的注册申请 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"gpt_icon":0},{"id":"1176630375","title":"Jade Biosciences宣布推出Jade201——一款在研的潜在同类最佳半衰期延长去岩藻糖化抗BAFF受体单克隆抗体,用于治疗自身免疫性疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1176630375","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176630375?lang=zh_cn&edition=full","pubTime":"2025-10-07 19:05","pubTimestamp":1759835128,"startTime":"0","endTime":"0","summary":"Jade Biosciences宣布推出Jade201——一款在研的潜在同类最佳半衰期延长去岩藻糖化抗BAFF受体单克隆抗体,用于治疗自身免疫性疾病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","JBIO"],"gpt_icon":0},{"id":"1184782676","title":"Jade Biosciences预计2026年上半年公布富含生物标志物的1期健康志愿者中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1184782676","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184782676?lang=zh_cn&edition=full","pubTime":"2025-09-02 19:18","pubTimestamp":1756811900,"startTime":"0","endTime":"0","summary":"Jade Biosciences预计2026年上半年公布富含生物标志物的1期健康志愿者中期数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","JBIO"],"gpt_icon":0},{"id":"1170017526","title":"Jade Biosciences宣布新型抗APRIL单抗药物Jade101的1期健康志愿者临床试验完成首批受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1170017526","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170017526?lang=zh_cn&edition=full","pubTime":"2025-09-02 19:01","pubTimestamp":1756810886,"startTime":"0","endTime":"0","summary":"Jade Biosciences公司宣布,其在研的新型抗APRIL单克隆抗体药物Jade101已完成1期健康志愿者临床试验的首批受试者给药。该药物被认为具有潜在的同类最佳特性,正在接受IgA肾病治疗适应症的评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"gpt_icon":0},{"id":"2543603850","title":"Guggenheim:上调Jade Biosciences(JBIO.US)评级,由中性调整至买入评级, 目标价14.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2543603850","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543603850?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:45","pubTimestamp":1750081519,"startTime":"0","endTime":"0","summary":"Guggenheim:上调Jade Biosciences(JBIO.US)评级,由中性调整至买入评级, 目标价14.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/16214551098389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["JBIO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jadebiosciences.com","stockEarnings":[{"period":"1week","weight":0.1096},{"period":"1month","weight":0.498},{"period":"3month","weight":0.9455},{"period":"6month","weight":1.216},{"period":"1year","weight":-0.8328},{"period":"ytd","weight":-0.8385}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Jade Biosciences, Inc.是内华达州的一家公司,专注于开发一流的疗法,以解决自身免疫性疾病中关键的未满足需求。其牵头资产JADE-001针对免疫球蛋白A(IGA)肾病的细胞因子抗-A PRoliferation诱导Ligand(APRIL),正在进行研究性新药应用赋能研究,预计将于2025年下半年启动首次人体试验。Jade的管线还包括两个未公开的抗体发现项目,JADE-002和JADE-003,目前处于临床前开发阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.093905},{"month":2,"riseRate":0.5,"avgChangeRate":0.00635},{"month":3,"riseRate":0.75,"avgChangeRate":0.252318},{"month":4,"riseRate":0.25,"avgChangeRate":-0.36998},{"month":5,"riseRate":0,"avgChangeRate":-0.15923},{"month":6,"riseRate":0.75,"avgChangeRate":-0.046284},{"month":7,"riseRate":0.6,"avgChangeRate":-0.036},{"month":8,"riseRate":0.6,"avgChangeRate":0.058197},{"month":9,"riseRate":0.6,"avgChangeRate":0.018606},{"month":10,"riseRate":0.6,"avgChangeRate":0.005142},{"month":11,"riseRate":0.6,"avgChangeRate":0.137722},{"month":12,"riseRate":0.8,"avgChangeRate":0.206347}],"exchange":"NASDAQ","name":"Jade Biosciences","nameEN":"Jade Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jade Biosciences(JBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Jade Biosciences(JBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Jade Biosciences,JBIO,Jade Biosciences股票,Jade Biosciences股票老虎,Jade Biosciences股票老虎国际,Jade Biosciences行情,Jade Biosciences股票行情,Jade Biosciences股价,Jade Biosciences股市,Jade Biosciences股票价格,Jade Biosciences股票交易,Jade Biosciences股票购买,Jade Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jade Biosciences(JBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Jade Biosciences(JBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}